Thyroid cancer: Advances in diagnostic research

Emmanuel Kwaku Ofori; Dziedzorm Wormenor; Eric Nana Yaw Nyarko

doi:10.1016/B978-0-443-33849-6.00012-X

Thyroid cancer: Advances in diagnostic research

Emmanuel Kwaku Ofori, Dziedzorm Wormenor, Eric Nana Yaw Nyarko

University of Ghana

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Thyroid cancer (TC) cases are not just a local concern, but a global issue on the rise. This necessitates a thorough evaluation of existing diagnostic methods. TC diagnosis adheres to the American Thyroid Association's recommendations, which involve laboratory testing, fine needle aspirate cytology, and biopsy. Ultrasonography, MRI, Positron Emission Tomography (PET), and CT scans are also essential in the diagnostic process. The measurement of serum TSH is critical for diagnosing several conditions, while the measurement of serum calcitonin assists in diagnosing medullary thyroid cancer. Recent advancements in the field have included molecular testing methods such as ThyroSeq and Afirma assays. These tests effectively minimize the necessity for diagnostic surgery and enhance diagnostic precision, indicating a significant change in thyroid cancer therapy toward improved patient outcomes.

Original language	English
Title of host publication	Diagnostic Landscape in Cancer Research
Publisher	Elsevier
Pages	235-246
Number of pages	12
ISBN (Electronic)	9780443338496
ISBN (Print)	9780443338502
DOIs	https://doi.org/10.1016/B978-0-443-33849-6.00012-X
Publication status	Published - 1 Jan 2025

Keywords

Calcitonin
Diagnosis
Fine needle aspirate
Molecular
Positron emission tomography
Thyroid cancer
Thyroid stimulating hormone
Ultrasound scan

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-443-33849-6.00012-X

Cite this

@inbook{d00ef9b964fb4673ab4a8d2f4c4d6eff,

title = "Thyroid cancer: Advances in diagnostic research",

abstract = "Thyroid cancer (TC) cases are not just a local concern, but a global issue on the rise. This necessitates a thorough evaluation of existing diagnostic methods. TC diagnosis adheres to the American Thyroid Association's recommendations, which involve laboratory testing, fine needle aspirate cytology, and biopsy. Ultrasonography, MRI, Positron Emission Tomography (PET), and CT scans are also essential in the diagnostic process. The measurement of serum TSH is critical for diagnosing several conditions, while the measurement of serum calcitonin assists in diagnosing medullary thyroid cancer. Recent advancements in the field have included molecular testing methods such as ThyroSeq and Afirma assays. These tests effectively minimize the necessity for diagnostic surgery and enhance diagnostic precision, indicating a significant change in thyroid cancer therapy toward improved patient outcomes.",

keywords = "Calcitonin, Diagnosis, Fine needle aspirate, Molecular, Positron emission tomography, Thyroid cancer, Thyroid stimulating hormone, Ultrasound scan",

author = "Ofori, \{Emmanuel Kwaku\} and Dziedzorm Wormenor and Nyarko, \{Eric Nana Yaw\}",

year = "2025",

month = jan,

day = "1",

doi = "10.1016/B978-0-443-33849-6.00012-X",

language = "English",

isbn = "9780443338502",

pages = "235--246",

booktitle = "Diagnostic Landscape in Cancer Research",

publisher = "Elsevier",

}

TY - CHAP

T1 - Thyroid cancer

T2 - Advances in diagnostic research

AU - Ofori, Emmanuel Kwaku

AU - Wormenor, Dziedzorm

AU - Nyarko, Eric Nana Yaw

PY - 2025/1/1

Y1 - 2025/1/1

N2 - Thyroid cancer (TC) cases are not just a local concern, but a global issue on the rise. This necessitates a thorough evaluation of existing diagnostic methods. TC diagnosis adheres to the American Thyroid Association's recommendations, which involve laboratory testing, fine needle aspirate cytology, and biopsy. Ultrasonography, MRI, Positron Emission Tomography (PET), and CT scans are also essential in the diagnostic process. The measurement of serum TSH is critical for diagnosing several conditions, while the measurement of serum calcitonin assists in diagnosing medullary thyroid cancer. Recent advancements in the field have included molecular testing methods such as ThyroSeq and Afirma assays. These tests effectively minimize the necessity for diagnostic surgery and enhance diagnostic precision, indicating a significant change in thyroid cancer therapy toward improved patient outcomes.

AB - Thyroid cancer (TC) cases are not just a local concern, but a global issue on the rise. This necessitates a thorough evaluation of existing diagnostic methods. TC diagnosis adheres to the American Thyroid Association's recommendations, which involve laboratory testing, fine needle aspirate cytology, and biopsy. Ultrasonography, MRI, Positron Emission Tomography (PET), and CT scans are also essential in the diagnostic process. The measurement of serum TSH is critical for diagnosing several conditions, while the measurement of serum calcitonin assists in diagnosing medullary thyroid cancer. Recent advancements in the field have included molecular testing methods such as ThyroSeq and Afirma assays. These tests effectively minimize the necessity for diagnostic surgery and enhance diagnostic precision, indicating a significant change in thyroid cancer therapy toward improved patient outcomes.

KW - Calcitonin

KW - Diagnosis

KW - Fine needle aspirate

KW - Molecular

KW - Positron emission tomography

KW - Thyroid cancer

KW - Thyroid stimulating hormone

KW - Ultrasound scan

UR - https://www.scopus.com/pages/publications/105011216069

U2 - 10.1016/B978-0-443-33849-6.00012-X

DO - 10.1016/B978-0-443-33849-6.00012-X

M3 - Chapter

AN - SCOPUS:105011216069

SN - 9780443338502

SP - 235

EP - 246

BT - Diagnostic Landscape in Cancer Research

PB - Elsevier

ER -

Thyroid cancer: Advances in diagnostic research

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this